MedPath

SUMATRIPTAN

SumatriptanNasal Spray

Approved
Approval ID

24bc527e-c682-4c66-964e-c21d31eca5dd

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 12, 2011

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sumatriptan

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-6052
Application NumberNDA020626
Product Classification
M
Marketing Category
C73594
G
Generic Name
sumatriptan
Product Specifications
Route of AdministrationNASAL
Effective DateDecember 12, 2011
FDA Product Classification

INGREDIENTS (6)

POTASSIUM PHOSPHATE, MONOBASICInactive
Code: 4J9FJ0HL51
Classification: IACT
SUMATRIPTANActive
Quantity: 20 mg in 100 uL
Code: 8R78F6L9VO
Classification: ACTIB
SODIUM PHOSPHATE, DIBASIC ANHYDROUSInactive
Code: 22ADO53M6F
Classification: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SUMATRIPTAN - FDA Drug Approval Details